How to Cite
Kovalenko, A., Liutkevich, A., BolgovМ., & Tarashchenko, Y. (2017). Polyglandular sporadic primary hyperparathyroidism (review of the literature and our ow n data) 6th Workshop of the European S ociety of Endocrine Surgeons (ESES), May 28 th-30st 2015, Varna, Bulgaria. Endokrynologia, 22(4), 356-374. Retrieved from https://endokrynologia.com.ua/index.php/journal/article/view/104
Abstract
The review describes the modern diagnosis and treatment trends polyglandular lesions parathyroid glands in primary hyperparathyroidism, which occurs often enough, from 8% to 33% of cases. This increases the rate of persistent disease after parathyroidectomy in comparison with patients with a solitary parathyroid adenoma. Discussed the issue of preoperative prediction polyglandular injury risk, the need for adequate intraoperative revision of the parathyroid glands and long-term monitoring after surgery in order to increase the effectiveness of treatment in this group of patients.
References
1. Westin G., Björklund P., Akerstrőm G. Molecular genetics of parathyroid disease // World J. Surg. — 2009. — Vol. 33. — P. 2224-2233.
2. Brown E.M. Clinical lessons from the calcium-sensing receptor // Nat. Clin. Pract. Endocrinol. Metab. — 2007. — Vol. 3. — P. 122-133.
3. Saunders B.D., Saunders E.F., Gauger P.G. Lithium therapy and hyperparathyroidism: an evidence-based assessment // World J. Surg. — 2009. — Vol. 33. — P. 2314-2323.
4. Sackett D.L. Rules of evidence and clinical recommendations on the use of antithrombotic agents // Chest. — 1989. — Vol. 95. (Suppl. 2). — P. 2s‑4s.
5. Heinrich S., Schafer M., Rousson V., Clavien P.A. Evidence-based treatment of acute pancreatitis: a look at established paradigms // Ann. Surg. — 2006. — Vol. 243. — P. 154-168.
6. Low R.A., Katz A.D. Parathyroidectomy via bilateral cervical exploration: a retrospective review of 866 cases // Head Neck. — 1998. — Vol. 20. — P. 583-587.
7. McGill J., Sturgeon C., Kaplan S.P., Chiu B., Kaplan E.L., Angelos P. How does the operative strategy for primary hyperparathyroidism impact the findings and cure rate? A
comparison of 800 parathyroidectomies // J. Am. Coll. Surg. — 2008. — Vol. 207. — P. 246-249.
8. Siperstein A., Berber E., Mackey R., Alghoul M., Wagner K., Milas M. Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism // Surgery. — 2004. — Vol. 136. — P. 872-880.
9. Russell C.F., Dolan S.J., Laird J.D. Randomized clinical trial comparing scan-directed unilateral versus bilateral cervical exploration for primary hyperparathyroidism due to solitary
adenoma // Br. J. Surg. — 2006. — Vol. 93. — P. 418-421.
10. Alhefdhi A., Schneider D.F., Sippel R., Chen H. Recurrent and persistence primary hyperparathyroidism occurs more frequently in patients with double adenomas // J. Surg. Res. — 2014. — Vol. 190. — P. 198-202.
11. Vandenbulcke O., Delaere P., Vander Poorten V., Debruyne F. Incidence of multiglandular disease in sporadic primary hyperparathyroidism // B-ENT. — 2014. — Vol. 10. — P. 1-6.
12. Mazeh H., Chen H., Leverson G., Sippel R.S. Creation of a «Wisconsin index» nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy // Ann. Surg. — 2013. — Vol. 257. — P. 138-141.
2. Brown E.M. Clinical lessons from the calcium-sensing receptor // Nat. Clin. Pract. Endocrinol. Metab. — 2007. — Vol. 3. — P. 122-133.
3. Saunders B.D., Saunders E.F., Gauger P.G. Lithium therapy and hyperparathyroidism: an evidence-based assessment // World J. Surg. — 2009. — Vol. 33. — P. 2314-2323.
4. Sackett D.L. Rules of evidence and clinical recommendations on the use of antithrombotic agents // Chest. — 1989. — Vol. 95. (Suppl. 2). — P. 2s‑4s.
5. Heinrich S., Schafer M., Rousson V., Clavien P.A. Evidence-based treatment of acute pancreatitis: a look at established paradigms // Ann. Surg. — 2006. — Vol. 243. — P. 154-168.
6. Low R.A., Katz A.D. Parathyroidectomy via bilateral cervical exploration: a retrospective review of 866 cases // Head Neck. — 1998. — Vol. 20. — P. 583-587.
7. McGill J., Sturgeon C., Kaplan S.P., Chiu B., Kaplan E.L., Angelos P. How does the operative strategy for primary hyperparathyroidism impact the findings and cure rate? A
comparison of 800 parathyroidectomies // J. Am. Coll. Surg. — 2008. — Vol. 207. — P. 246-249.
8. Siperstein A., Berber E., Mackey R., Alghoul M., Wagner K., Milas M. Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism // Surgery. — 2004. — Vol. 136. — P. 872-880.
9. Russell C.F., Dolan S.J., Laird J.D. Randomized clinical trial comparing scan-directed unilateral versus bilateral cervical exploration for primary hyperparathyroidism due to solitary
adenoma // Br. J. Surg. — 2006. — Vol. 93. — P. 418-421.
10. Alhefdhi A., Schneider D.F., Sippel R., Chen H. Recurrent and persistence primary hyperparathyroidism occurs more frequently in patients with double adenomas // J. Surg. Res. — 2014. — Vol. 190. — P. 198-202.
11. Vandenbulcke O., Delaere P., Vander Poorten V., Debruyne F. Incidence of multiglandular disease in sporadic primary hyperparathyroidism // B-ENT. — 2014. — Vol. 10. — P. 1-6.
12. Mazeh H., Chen H., Leverson G., Sippel R.S. Creation of a «Wisconsin index» nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy // Ann. Surg. — 2013. — Vol. 257. — P. 138-141.
Downloads
Download data is not yet available.